These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19496102)

  • 1. Does defense style or psychological mindedness predict treatement response in major depression?
    Kronström K; Salminen JK; Hietala J; Kajander J; Vahlberg T; Markkula J; Rasi-Hakala H; Karlsson H
    Depress Anxiety; 2009; 26(7):689-95. PubMed ID: 19496102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.
    Salminen JK; Karlsson H; Hietala J; Kajander J; Aalto S; Markkula J; Rasi-Hakala H; Toikka T
    Psychother Psychosom; 2008; 77(6):351-7. PubMed ID: 18701831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Psychodynamic Psychotherapy with Mentalization-Based Techniques in Major Depressive Disorder patients: Relationship among alexithymia, reflective functioning, and outcome variables - A Pilot study.
    Bressi C; Fronza S; Minacapelli E; Nocito EP; Dipasquale E; Magri L; Lionetti F; Barone L
    Psychol Psychother; 2017 Sep; 90(3):299-313. PubMed ID: 27801544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported immature defense style as a predictor of outcome in short-term and long-term psychotherapy.
    Laaksonen MA; Sirkiä C; Knekt P; Lindfors O
    Brain Behav; 2014 Jul; 4(4):495-503. PubMed ID: 25161816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
    Petersen T; Harley R; Papakostas GI; Montoya HD; Fava M; Alpert JE
    Psychol Med; 2004 Apr; 34(3):555-61. PubMed ID: 15259840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design.
    Menchetti M; Bortolotti B; Rucci P; Scocco P; Bombi A; Berardi D;
    BMC Psychiatry; 2010 Nov; 10():97. PubMed ID: 21108824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ego-defense mechanisms and brief psychotherapies for the management of major depressive disorder in adults: A longitudinal and quasi-experimental study.
    da Silva Machado R; Vieira IS; Scaini C; Molina ML; Barbosa LP; da Silva GDG; Ores L; de Mattos Souza LD; Jansen K; da Silva RA
    J Affect Disord; 2023 Jun; 330():291-299. PubMed ID: 36871912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
    Knekt P; Lindfors O; Härkänen T; Välikoski M; Virtala E; Laaksonen MA; Marttunen M; Kaipainen M; Renlund C;
    Psychol Med; 2008 May; 38(5):689-703. PubMed ID: 18005493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preference compared with random allocation in short-term psychodynamic supportive psychotherapy with indicated addition of pharmacotherapy for depression.
    Van HL; Dekker J; Koelen J; Kool S; van Aalst G; Hendriksen M; Peen J; Schoevers R
    Psychother Res; 2009 Mar; 19(2):205-12. PubMed ID: 19396651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immature defense mechanisms predict poor response to psychotherapy in major depressive patients with comorbid cluster B personality disorder.
    Scaini CR; Vieira IS; Machado R; de Azevedo Cardoso T; Mondin T; Souza L; Molina ML; Jansen K; da Silva RA
    Braz J Psychiatry; 2022 Nov; 44(5):469-477. PubMed ID: 35896153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of brief interpersonal psychotherapy for depression among women.
    Swartz HA; Frank E; Shear MK; Thase ME; Fleming MA; Scott J
    Psychiatr Serv; 2004 Apr; 55(4):448-50. PubMed ID: 15067162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.
    Hunter AM; Cook IA; Greenwald SD; Tran ML; Miyamoto KN; Leuchter AF
    J Clin Neurophysiol; 2011 Oct; 28(5):478-82. PubMed ID: 21946361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
    March J; Silva S; Vitiello B;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
    Peselow ED; Tobia G; Karamians R; Pizano D; IsHak WW
    Psychiatry Res; 2015 Feb; 225(3):680-6. PubMed ID: 25496869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in Defense Mechanisms and Depression in a Pilot Study of Antidepressive Medications Plus 20 Sessions of Psychotherapy for Recurrent Major Depression.
    Perry JC; Banon E; Bond M
    J Nerv Ment Dis; 2020 Apr; 208(4):261-268. PubMed ID: 32221178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
    Papakostas GI; Petersen T; Sklarsky KG; Nierenberg AA; Alpert JE; Fava M
    Psychiatry Res; 2007 Jan; 149(1-3):195-200. PubMed ID: 17157390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.